BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2018
View Archived Issues
Pancreatic map gives clues to disease
Read More
Discovery of a prognostic microRNA for p53-like bladder cancers using ActMiR computation
Read More
KinoPharma establishes collaboration for research in Alzheimer's disease
Read More
GSK-701: a first-in-class clinical antimalarial candidate with good oral bioavailability
Read More
Virus-based vaccine shows promise as candidate for Zika virus
Read More
SLC10A7 gene mutations implicated in skeletal dysplasia
Read More
Finally, the best of both worlds? Bifunctional opioid agonist fights pain, and addiction
Read More
Phase II PANTHEON results for neladenoson bialanate in heart failure patients reported
Read More
Astellas Pharma discloses KRAS Gly12Cys mutant inhibitors
Read More
Merck & Co. optimizes newly discovered IDO1 inhibitors
Read More
Duzallo, a fixed-dose combination therapy for gout, approved in Europe
Read More
Low levels of CDKN1C indicate LV dysfunction risk in women after myocardial infarction
Read More
Positive XEN-1101 pharmacodynamic data from Xenon's phase Ib TMS study
Read More
Lenvima capsules approved for first-line treatment of HCC in South Korea
Read More
Vertex and Genomics collaborate to advance discovery of precision medicines
Read More
Sophiris Bio announces update on phase IIb trial in localized prostate cancer
Read More
Poxel acquires DRX-065 and portfolio of additional deuterated drug candidates
Read More
First patient dosed in phase II clinical trial in Duchenne muscular dystrophy
Read More
Blincyto approved for use in pediatric patients with Ph- relapsed or refractory B-cell precursor ALL
Read More
